Methodological considerations on paracetamol pharmacokinetics in spinal muscular atrophy: A response to Zhao et al.

Documenti analoghi

• The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations
  di: Andrej Belančić, et al.
  Pubblicazione: (2026)
• Time to accelerate rare disease research: AI‐powered in silico trials, digital twin‐driven RCTs and decision‐grade real‐world evidence
  di: Andrej Belančić, et al.
  Pubblicazione: (2026)
• The cost‐effectiveness of cystic fibrosis transmembrane conductance regulator modulators: A systematic review of economic evaluations
  di: Andrea Katrin Faour, et al.
  Pubblicazione: (2025)
• Digital twins: Unlocking comparative evidence that clinical research urgently needs
  di: Andrej Belančić, et al.
  Pubblicazione: (2025)
• Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers
  di: Andrej Belančić, et al.
  Pubblicazione: (2025)